For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Myeloid Therapeutics, Inc.

USPTO Granted Patents = 13

Forward Citations = 31

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Daniel Getts (10 out of 10 patents)

Yuxiao Wang (10 out of 10 patents)

Boris Minev (3 out of 10 patents)

4. Amit N Patel (3 out of 23 patents)

5. Santosh Kesari (3 out of 9 patents)

6. Samuel C Wagner (3 out of 4 patents)

7. Thomas E Ichim (3 out of 3 patents)

8. Julia S Szymanski (3 out of 3 patents)

9. Namita Bisaria (3 out of 4 patents)

10. Inna Shcherbakova (2 out of 2 patents)

11. Socheata Ly (2 out of 2 patents)

12. Bruce McCreedy, Jr (2 out of 2 patents)

13 patents: Sort by Forward Citations

1. 12766198 - METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION (2026-10-20),

2. 12319925 - Methods and compositions for genomic integration (2025-06-03),

3. 12252545 - Therapeutic cell compositions and methods of manufacturing and use thereof (2025-03-18),

4. 12030938 - Engineered chimeric fusion protein compositions and methods of use thereof (2024-07-09),

5. 11944680 - Engineered chimeric fusion protein compositions and methods of use thereof (2024-04-02),

6. 11918605 - Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer (2024-03-05),

7. 11918604 - Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer (2024-03-05),

8. 11672874 - Methods and compositions for genomic integration (2023-06-13),

9. 11628218 - Engineered chimeric fusion protein compositions and methods of use thereof (2023-04-18),

10. 11517589 - Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer (2022-12-06),

11. 11026973 - Engineered phagocytic receptor compositions and methods of use thereof (2021-06-08),

12. 11013764 - Engineered phagocytic receptor compositions and methods of use thereof (2021-05-25),

13. 10980836 - Therapeutic cell compositions and methods of manufacturing and use thereof (2021-04-20),

Company Overview

Myeloid Therapeutics, Inc. is a biotechnology company based in Boston, MA, focused on advancing innovative therapies for cancer and other serious diseases. The company specializes in harnessing the power of myeloid cells to develop transformative treatments that aim to enhance the immune response against tumors. Myeloid Therapeutics is dedicated to pioneering research in the field of immuno-oncology, leveraging cutting-edge technologies to create novel therapeutic approaches that address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#157 in Boston, MA

#1,443 in Massachusetts

#23,854 in US

#45,081 in the World

Boston, MA, United States of America

Myeloid Therapeutics, Inc.

Forward Citations = 31

12 inventors:

Daniel Getts (10 out of 10 patents)

Yuxiao Wang (10 out of 10 patents)

Boris Minev (3 out of 10 patents)

4. Amit N Patel (3 out of 23 patents)

5. Santosh Kesari (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Myeloid Therapeutics, Inc.. Retrieved from https://idiyas.com/company/myeloid-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…